Moreover, by multiple databases, we speculated that for PRAD patients with metastasis, HSPB1 could up-regulating the PIP5K1C − 46,721 − AT by the pathway of Alzheimer’s disease which was also related to prognosis. This evidence concerns the gene HSPB1 and prostate adenocarcinoma.